| Company Name | iCAD |
| Founded | 1984 |
| Head office | Nashua, United States |
| Website | http://www.icadmed.com/ |
| Contact | sales@rmsmedicaldevices.nl |
Products by iCAD
Subspeciality: Breast
Modality: Mammography
Source: Vendor
Calcification detection, Case scoring, Certainty scoring, Malignancy detection
The concurrent-read, cancer detection and workflow solution from iCAD analyzes each tomosynthesis image, detecting both malignant soft tissue densities and calcifications. Built on deep-learning and artificial intelligence technology, ProFound AI for breast tomosynthesis assists radiologists in addressing the challenges of reading tomosynthesis. Formerly branded as PowerLook Tomo Detection 2.0
Subspeciality: Breast
Modality: Mammography
Source: Vendor
Calcification detection, Case scoring, Certainty scoring, Malignancy detection
Designed for radiologists, ProFound AI™ for 2D Mammography analyzes each image, detecting both malignant soft tissue densities and calcifications.
Subspeciality: Breast
Modality: Mammography
Source: Vendor
Individual 1y/2y/3y breast cancer risk score
ProFound AI risk is a clinical decision support tool that provides personalized one-, two-, and three-year breast cancer risk estimates based on 2D screening mammograms or 3D breast tomosynthesis. ProFound AI Risk combines a range of risk factors (age, density, subtle mammographic features) to produce short-term risk assessments that physicians can use to create customized screening plans and catch early-stage cancers.